Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 10Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Rhabdomyosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Desmoplastic Small Round Cell Tumor 2Brain Neoplasms 2Stage IA Uterine Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Malignant mesenchymal tumor 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Endometrial Clear Cell Adenocarcinoma 1Carcinosarcoma 1Astrocytoma 1

Interventions

Doxorubicin 18Ifosfamide 13Radiotherapy 8Paclitaxel 7pazopanib 6pembrolizumab 4Gemcitabine 4Filgrastim 4Chemotherapy, Adjuvant 4Bevacizumab 4spartalizumab 3durvalumab 3Sorafenib 3Propranolol 3Nivolumab 3Ipilimumab 3Imatinib Mesylate 3Etoposide 3Epirubicin 3Docetaxel 3Carboplatin 3trebananib 2regorafenib 2cixutumumab 2cemiplimab 2carotuximab 2brostallicin 2belinostat 2balstilimab 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiosarcoma × Brachytherapy × Sarcoma × Clear all
NCT00002898 2013-12-04

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡